Hepatitis C Virus (HCV) Constitutively Activates STAT-3 via Oxidative Stress: Role of STAT-3 in HCV Replication

ABSTRACT The hepatitis C virus (HCV) causes chronic hepatitis, which often results in liver cirrhosis and hepatocellular carcinoma. We have previously shown that HCV nonstructural proteins induce activation of STAT-3 via oxidative stress and Ca2+ signaling (G. Gong, G. Waris, R. Tanveer, and A. Siddiqui, Proc. Natl. Acad. Sci. USA 98:9599-9604, 2001). In this study, we focus on the signaling pathway leading to STAT-3 activation in response to oxidative stress induced by HCV translation and replication activities. Here, we demonstrate the constitutive activation of STAT-3 in HCV replicon-expressing cells. The HCV-induced STAT-3 activation was inhibited in the presence of antioxidant (pyrrolidine dithiocarbamate) and Ca2+ chelators (BAPTA-AM and TMB-8). Previous studies have shown that maximum STAT-3 transactivation requires Ser727 phosphorylation in addition to tyrosine phosphorylation. Using a series of inhibitors and dominant negative mutants, we show that HCV-induced activation of STAT-3 is mediated by oxidative stress and influenced by the activation of cellular kinases, including p38 mitogen-activated protein kinase, JNK, JAK-2, and Src. Our results also suggest a potential role of STAT-3 in HCV RNA replication. We also observed the constitutive activation of STAT-3 in the liver biopsy of an HCV-infected patient. These studies provide an insight into the mechanisms by which HCV induces intracellular events relevant to liver pathogenesis associated with the viral infection.

[1]  Hua Yu,et al.  The STATs of cancer — new molecular targets come of age , 2004, Nature Reviews Cancer.

[2]  H. Young,et al.  Inactivation of Stat3 in tumor cells: releasing a brake on immune responses against cancer? , 2004, Cancer cell.

[3]  A. Siddiqui,et al.  Two-step affinity purification of the hepatitis C virus ribonucleoprotein complex. , 2004, RNA.

[4]  J. Darnell,et al.  Essential Role of STAT3 in Postnatal Survival and Growth Revealed by Mice Lacking STAT3 Serine 727 Phosphorylation , 2004, Molecular and Cellular Biology.

[5]  M. Lai,et al.  Reactive oxygen species suppress hepatitis C virus RNA replication in human hepatoma cells , 2004, Hepatology.

[6]  Nicola Gebbia,et al.  STAT proteins: From normal control of cellular events to tumorigenesis , 2003, Journal of cellular physiology.

[7]  A. Siddiqui,et al.  Hepatitis C Virus NS5A and Subgenomic Replicon Activate NF-κB via Tyrosine Phosphorylation of IκBα and Its Degradation by Calpain Protease* , 2003, Journal of Biological Chemistry.

[8]  R. Levy,et al.  The human type I interferon receptor: NMR structure reveals the molecular basis of ligand binding. , 2003, Structure.

[9]  Jin-Xiong She,et al.  Gene expression associated with interferon alfa antiviral activity in an HCV replicon cell line , 2003, Hepatology.

[10]  Soon B. Hwang,et al.  Hepatitis C Virus RNA Replication Occurs on a Detergent-Resistant Membrane That Cofractionates with Caveolin-2 , 2003, Journal of Virology.

[11]  F. Penin,et al.  Interaction of hepatitis C virus proteins with host cell membranes and lipids. , 2002, Trends in cell biology.

[12]  Wei Li,et al.  STAT3 Contributes to the Mitogenic Response of Hepatocytes during Liver Regeneration* , 2002, The Journal of Biological Chemistry.

[13]  A. Siddiqui,et al.  Hepatitis C Virus Subgenomic Replicons Induce Endoplasmic Reticulum Stress Activating an Intracellular Signaling Pathway , 2002, Journal of Virology.

[14]  A. Siddiqui,et al.  Interaction between STAT-3 and HNF-3 Leads to the Activation of Liver-Specific Hepatitis B Virus Enhancer 1 Function , 2002, Journal of Virology.

[15]  Frank Scholle,et al.  Mitochondrial injury, oxidative stress, and antioxidant gene expression are induced by hepatitis C virus core protein. , 2002, Gastroenterology.

[16]  N. Terrault,et al.  Hepatitis C and hepatocellular carcinoma , 2001, Current treatment options in oncology.

[17]  R. Bartenschlager,et al.  Novel cell culture systems for the hepatitis C virus. , 2001, Antiviral research.

[18]  V. Bichko,et al.  Effect of Alpha Interferon on the Hepatitis C Virus Replicon , 2001, Journal of Virology.

[19]  A. Siddiqui,et al.  Human hepatitis C virus NS5A protein alters intracellular calcium levels, induces oxidative stress, and activates STAT-3 and NF-κB , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[20]  Zhenming Xu,et al.  Synthesis of a novel hepatitis C virus protein by ribosomal frameshift , 2001, The EMBO journal.

[21]  T. Yeatman,et al.  Stat3-mediated Myc expression is required for Src transformation and PDGF-induced mitogenesis , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[22]  J. Vinel,et al.  Nonstructural 3 Protein of Hepatitis C Virus Triggers an Oxidative Burst in Human Monocytes via Activation of NADPH Oxidase* , 2001, The Journal of Biological Chemistry.

[23]  R. Bartenschlager,et al.  Mutations in Hepatitis C Virus RNAs Conferring Cell Culture Adaptation , 2001, Journal of Virology.

[24]  J. Turkson,et al.  Induction of p21WAF1/CIP1 and cyclin D1 expression by the Src oncoprotein in mouse fibroblasts: role of activated STAT3 signaling , 2000, Oncogene.

[25]  J. Turkson,et al.  Activation of Stat3 in v-Src-transformed Fibroblasts Requires Cooperation of Jak1 Kinase Activity* , 2000, The Journal of Biological Chemistry.

[26]  Roy Garcia,et al.  STATs in oncogenesis , 2000, Oncogene.

[27]  R. Bartenschlager,et al.  Replication of hepatitis C virus. , 2000, The Journal of general virology.

[28]  U. Rapp,et al.  Influenza Virus-induced NF-κB-dependent Gene Expression Is Mediated by Overexpression of Viral Proteins and Involves Oxidative Radicals and Activation of IκB Kinase* , 2000, The Journal of Biological Chemistry.

[29]  J. Turkson,et al.  Requirement for Ras/Rac1-Mediated p38 and c-Jun N-Terminal Kinase Signaling in Stat3 Transcriptional Activity Induced by the Src Oncoprotein , 1999, Molecular and Cellular Biology.

[30]  M. Jaroszeski,et al.  Gene therapy with dominant-negative Stat3 suppresses growth of the murine melanoma B16 tumor in vivo. , 1999, Cancer research.

[31]  S. Pellegrini,et al.  The Janus kinase family of protein tyrosine kinases and their role in signaling , 1999, Cellular and Molecular Life Sciences CMLS.

[32]  J. Darnell,et al.  Stat3 as an Oncogene , 1999, Cell.

[33]  H. Pahl.  Signal transduction from the endoplasmic reticulum to the cell nucleus. , 1999, Physiological reviews.

[34]  R. El Bekay,et al.  Oxidative Stress Triggers STAT3 Tyrosine Phosphorylation and Nuclear Translocation in Human Lymphocytes* , 1999, The Journal of Biological Chemistry.

[35]  B. Cochran,et al.  Activation of the JAK-STAT pathway by reactive oxygen species. , 1998, American journal of physiology. Cell physiology.

[36]  R. Jove,et al.  Activation of STAT transcription factors in oncogenic tyrosine kinase signaling. , 1998, Journal of biomedical science.

[37]  J. Turkson,et al.  Stat3 Activation by Src Induces Specific Gene Regulation and Is Required for Cell Transformation , 1998, Molecular and Cellular Biology.

[38]  T. Finkel.  Oxygen radicals and signaling. , 1998, Current opinion in cell biology.

[39]  M. Ishida,et al.  c-Src Is Required for Oxidative Stress-mediated Activation of Big Mitogen-activated Protein Kinase 1 (BMK1)* , 1997, The Journal of Biological Chemistry.

[40]  C. Rice,et al.  Transmission of hepatitis C by intrahepatic inoculation with transcribed RNA. , 1997, Science.

[41]  A. Nomoto,et al.  Genetic analysis of internal ribosomal entry site on hepatitis C virus RNA: implication for involvement of the highly ordered structure and cell type-specific transacting factors. , 1997, Virology.

[42]  J. Juszczyk,et al.  Reduced glutathione concentration in erythrocytes of patients with acute and chronic viral hepatitis , 1997, Journal of viral hepatitis.

[43]  R. Jove,et al.  Constitutive Activation of JAK1 in Src-transformed Cells* , 1997, The Journal of Biological Chemistry.

[44]  S. Constantinescu,et al.  Direct Association of STAT3 with the IFNAR-1 Chain of the Human Type I Interferon Receptor (*) , 1996, The Journal of Biological Chemistry.

[45]  N. Kato,et al.  A novel sequence found at the 3' terminus of hepatitis C virus genome. , 1995, Biochemical and biophysical research communications.

[46]  J. Darnell,et al.  Maximal activation of transcription by statl and stat3 requires both tyrosine and serine phosphorylation , 1995, Cell.

[47]  R. Jove,et al.  Enhanced DNA-binding activity of a Stat3-related protein in cells transformed by the Src oncoprotein. , 1995, Science.

[48]  A. Floreani,et al.  Iron storage, lipid peroxidation and glutathione turnover in chronic anti-HCV positive hepatitis. , 1995, Journal of hepatology.

[49]  J. Darnell,et al.  Stat3: a STAT family member activated by tyrosine phosphorylation in response to epidermal growth factor and interleukin-6. , 1994, Science.

[50]  T. Yen,et al.  Negative regulation of hepatitis B virus gene expression and replication by oxidative stress. , 1994, The Journal of biological chemistry.

[51]  Masatoshi Hagiwara,et al.  Phosphorylated CREB binds specifically to the nuclear protein CBP , 1993, Nature.

[52]  A. Siddiqui,et al.  Translation of human hepatitis C virus RNA in cultured cells is mediated by an internal ribosome-binding mechanism , 1993, Journal of virology.

[53]  F. Müller,et al.  Reactive oxygen intermediates and human immunodeficiency virus (HIV) infection. , 1992, Free radical biology & medicine.

[54]  Tony Hunter,et al.  The regulation of transcription by phosphorylation , 1992, Cell.

[55]  A. Nomoto,et al.  Internal ribosome entry site within hepatitis C virus RNA , 1992, Journal of virology.

[56]  P. Baeuerle,et al.  Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF‐kappa B transcription factor and HIV‐1. , 1991, The EMBO journal.

[57]  K. Wood,et al.  Firefly luciferase gene: structure and expression in mammalian cells , 1987, Molecular and cellular biology.

[58]  G. De Sandre,et al.  Severe impairment of antioxidant system in human hepatoma , 1986, Cancer.

[59]  Hua Yu,et al.  Regulation of the innate and adaptive immune responses by Stat-3 signaling in tumor cells , 2004, Nature Medicine.

[60]  C. Rice,et al.  Overview of hepatitis C virus genome structure, polyprotein processing, and protein properties. , 2000, Current topics in microbiology and immunology.

[61]  J. Turkson,et al.  Constitutive activation of Stat3 signaling confers resistance to apoptosis in human U266 myeloma cells. , 1999, Immunity.

[62]  J. Silver,et al.  Replication of Subgenomic Hepatitis C Virus Rnas in a Hepatoma Cell Line , 1999 .

[63]  G. P. Studzinski.  Apoptosis : a practical approach , 1999 .

[64]  D. V. van Thiel,et al.  Association between reactive oxygen species and disease activity in chronic hepatitis C. , 1996, Free radical biology & medicine.

[65]  Y. Sun,et al.  Free radicals, antioxidant enzymes, and carcinogenesis. , 1990, Free radical biology & medicine.